» Articles » PMID: 2687883

Lack of a Negative Influence on Viral Growth by the Nef Gene of Human Immunodeficiency Virus Type 1

Overview
Specialty Science
Date 1989 Dec 1
PMID 2687883
Citations 94
Authors
Affiliations
Soon will be listed here.
Abstract

Human immunodeficiency virus type 1 (HIV-1) contains an open reading frame called nef at the 3' end of its genome. The nef gene product has been reported to down-regulate viral growth by suppressing viral transcription through interaction with the long terminal repeat region. We have compared two isogenic HIV-1 (HIV-1-WI3) strains, one of which lacks nef expression, and found little difference between them in in vitro growth. We tested effects on viral entry, DNA synthesis, and RNA expression by measuring HIV-specific low molecular weight DNA and RNA after infection. The qualitative and quantitative aspects of DNA and RNA synthesis were comparable between the nef+ and nef- strains. The effects on viral growth were also examined by following changes in reverse transcriptase activity during the course of infection. The presence of the nef gene product failed to slow viral growth in several different cell types tested, including the human T-lymphocyte cell lines H9 and CEM-SS, human primary T cells enriched for CD4+ cells, and human monocytic cell lines U-937 and THP-1. On the contrary, the nef+ strain grew more efficiently in some cell types than the nef- strain. The same results were obtained with nef+ and nef- strains of a different virus, HIV-1-432, whose Nef had been reported to have a negative effect on viral growth. Our data suggest that the Nef protein does not act as a negative factor, at least in the experimental systems employed in our studies.

Citing Articles

No detectable differences in Nef-mediated downregulation of HLA-I and CD4 molecules among HIV-1 group M lineages circulating in Cameroon, where the pandemic originated.

Sonela N, Mann J, Godwe C, Goni O, Tchakoute M, Nkoue N Front Virol. 2024; 4.

PMID: 38883214 PMC: 7616105. DOI: 10.3389/fviro.2024.1379217.


AP-2 Adaptor Complex-Dependent Enhancement of HIV-1 Replication by Nef in the Absence of the Nef/AP-2 Targets SERINC5 and CD4.

Olety B, Usami Y, Wu Y, Peters P, Gottlinger H mBio. 2023; 14(1):e0338222.

PMID: 36622146 PMC: 9973267. DOI: 10.1128/mbio.03382-22.


Extracellular vesicles in virus infection and pathogenesis.

McNamara R, Dittmer D Curr Opin Virol. 2020; 44:129-138.

PMID: 32846272 PMC: 7755726. DOI: 10.1016/j.coviro.2020.07.014.


A Conserved Acidic-Cluster Motif in SERINC5 Confers Partial Resistance to Antagonism by HIV-1 Nef.

Stoneham C, Ramirez P, Singh R, Suarez M, Debray A, Lim C J Virol. 2020; 94(7).

PMID: 31941773 PMC: 7081897. DOI: 10.1128/JVI.01554-19.


HIV-1 Impairment via UBE3A and HIV-1 Nef Interactions Utilizing the Ubiquitin Proteasome System.

Pyeon D, Rojas V, Price L, Kim S, Meharvan S, Park I Viruses. 2019; 11(12).

PMID: 31783587 PMC: 6950590. DOI: 10.3390/v11121098.


References
1.
Southern E . Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol. 1975; 98(3):503-17. DOI: 10.1016/s0022-2836(75)80083-0. View

2.
Hammes S, Dixon E, Malim M, Cullen B, Greene W . Nef protein of human immunodeficiency virus type 1: evidence against its role as a transcriptional inhibitor. Proc Natl Acad Sci U S A. 1989; 86(23):9549-53. PMC: 298534. DOI: 10.1073/pnas.86.23.9549. View

3.
Tsuchiya S, Yamabe M, Yamaguchi Y, Kobayashi Y, Konno T, Tada K . Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int J Cancer. 1980; 26(2):171-6. DOI: 10.1002/ijc.2910260208. View

4.
Poiesz B, Ruscetti F, Gazdar A, Bunn P, Minna J, Gallo R . Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A. 1980; 77(12):7415-9. PMC: 350514. DOI: 10.1073/pnas.77.12.7415. View

5.
Lemischka I, Farmer S, Racaniello V, Sharp P . Nucleotide sequence and evolution of a mammalian alpha-tubulin messenger RNA. J Mol Biol. 1981; 151(1):101-20. DOI: 10.1016/0022-2836(81)90223-0. View